Le Lézard
Classified in: Business
Subject: STH

Canadian Investment Regulatory Organization Trading Halt - JRV


VANCOUVER, BC, June 27, 2023 /CNW/ - The following issues have been halted by CIRO

Company: Jervois Global Limited

TSX-Venture Symbol: JRV

All Issues: Yes

Reason: Pending News

Halt Time (ET): 8:21 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 06:25
MUFG Bank, Ltd. Company name: Mitsubishi UFJ Financial Group, Inc. Stock exchange listings: Tokyo, Nagoya, New York Code number: 8306 URL https://www.mufg.jp/ Representative: Hironori...

at 06:24
ACE Money Transfer, a leading global money transfer service, has secured a Payment Institution License from the Central Bank of Ireland. After months of thorough assessment and evaluation by the Irish Regulator, this significant milestone highlights...

at 06:21
Infosys (NSE: INFY) (BSE: INFY) , a global leader in next-generation digital services and consulting, today announced that it is collaborating with SAP Emarsys, a cloud-based, omnichannel customer engagement platform, to empower businesses to address...

at 06:15
In May, Virtual Gurus, a leader in virtual assistant solutions, appointed Elliot Schneier as Chief Operating Officer, setting the stage for significant organizational growth. Founded by Bobbie Racette, Virtual Gurus has empowered over 800...

at 06:15
AtkinsRéalis [SNC-Lavalin Group Inc.] , a fully integrated professional services and project management company with offices around the world, today announced its financial results for the first quarter ended March 31, 2024. AtkinsRéalis reports a...

at 06:15
MediPharm Labs Corp. ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial results for the three months ended March 31, 2024....



News published on and distributed by: